Latest Ischemia Stories
Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStemÂ®, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.
Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices.
PORTOLA VALLEY, Calif., Feb. 10, 2011 /PRNewswire/ -- Spectros Corporation announces that sales and licensing revenue rose 32% (year-over-year) in 2010. This is the third year in a row for double-digit revenue growth for Spectros since the current T-Stat product line was launched in 2008.
MOUNTAIN VIEW, Calif., Feb. 9, 2011 /PRNewswire/ -- Concentric Medical, Inc.
MOUNTAIN VIEW, Calif., Jan.
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart attack).
A new study identifies a molecule that is a critical regulator of neuron survival after ischemic brain injury.
CLEVELAND, Jan. 3, 2011 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S.
MERION STATION, Pa., Dec. 8, 2010 /PRNewswire-USNewswire/ -- After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it? While researching cardiac arrest, Jeffrey Dobkin read about a boy drowning in icy waters.
SAN DIEGO, Dec.
- Withering but not falling off, as a blossom that persists on a twig after flowering.